Science Explorer Back to mapMap
Discussion
Researcher · Anhui Medical University · China

Xiao‐Ming Meng

Xiao‐Ming Meng publishes mostly in Molecular Biology, Nephrology and Cancer Research, on topics such as Liver Disease Diagnosis and Treatment, Liver physiology and pathology and Chronic Kidney Disease and Diabetes.

ORCID 0000-0002-1166-561X OpenAlex
World rank
#61,828
of 7,710,434 ranked researchers
Rank in China
#4,755
of 978,568
Works
307
Citations
20k
Citations per work
65.7
h-index
65
i10-index 230Top 1.5% in Molecular Biology
Xiao‐Ming Meng

What does Xiao‐Ming Meng research?

Xiao‐Ming Meng's work is mostly in Biochemistry, Genetics and Molecular Biology (37%), Medicine (22%), Immunology and Microbiology (6%).

Life Sciences: 132 works · 43.0% of their workBiochemistry, Genetics and Molecular Biology: 112 works · 36.6% of their workMolecular Biology: 92 works · 29.9% of their workCancer Research: 21 works · 6.7% of their workImmunology and Microbiology: 20 works · 6.4% of their workImmunology: 20 works · 6.4% of their workEverything else: 107 works · 34.8% of their workHealth Sciences: 68 works · 22.2% of their workMedicine: 68 works · 22.2% of their workNephrology: 31 works · 10.2% of their workHepatology: 19 works · 6.1% of their workEpidemiology: 18 works · 5.9% of their workTHEIR WORKXiao‐Ming Meng307works
Life Sciences43%Health Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology11236.6%
    2. Immunology and Microbiology206.4%
  2. Everything else10734.8%
    1. Medicine6822.2%
  1. 1Molecular Biology30% of their works
  2. 2Nephrology10% of their works
  3. 3Cancer Research7% of their works
  4. 4Immunology6% of their works
  5. 5Hepatology6% of their works
  6. 6Epidemiology6% of their works

Research topics

Which keywords describe Xiao‐Ming Meng's research?

The keywords of their largest research topics: Chronic Kidney Disease, Biomarkers, Cancer, NAFLD, NASH, Hepatic Stellate Cells, Liver Regeneration and Cardiovascular Disease.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Chronic Kidney Disease622 topics
  2. Biomarkers502 topics
  3. Cancer482 topics
  4. NAFLD421 topic
  5. NASH421 topic
  6. Hepatic Stellate Cells411 topic
  7. Liver Regeneration411 topic
  8. Cardiovascular Disease381 topic
  9. Glomerular Filtration Rate381 topic
  10. Gene Expression261 topic
  11. MicroRNA261 topic
  12. RNA methylation261 topic
  13. m6A-seq261 topic
  14. Kidney Organoids251 topic
  15. Nephrogenesis251 topic
  16. Acute Kidney Injury241 topic
  17. Renal Failure241 topic
  18. Long Noncoding RNAs221 topic
  19. RNA Regulation221 topic

Where does Xiao‐Ming Meng work?

Xiao‐Ming Meng's main affiliation in the publication record is Anhui Medical University, China.

How many publications and citations does Xiao‐Ming Meng have?

OpenAlex counts 307 works and 20,158 citations for Xiao‐Ming Meng, an h-index of 65, ranking #61,828 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Xiao‐Ming Meng. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.